MC1651A1 - Gluconate de l'amino-2 ethoxycarbonylamino-3(fluoro-4 benzylamino)-6 pyridine et compositions pharmaceutiques renfermant ce compose - Google Patents
Gluconate de l'amino-2 ethoxycarbonylamino-3(fluoro-4 benzylamino)-6 pyridine et compositions pharmaceutiques renfermant ce composeInfo
- Publication number
- MC1651A1 MC1651A1 MC851765A MC1765A MC1651A1 MC 1651 A1 MC1651 A1 MC 1651A1 MC 851765 A MC851765 A MC 851765A MC 1765 A MC1765 A MC 1765A MC 1651 A1 MC1651 A1 MC 1651A1
- Authority
- MC
- Monaco
- Prior art keywords
- ethoxycarbonylamino
- benzylamino
- fluoro
- amino
- gluconate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/10—Polyhydroxy carboxylic acids
- C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843416609 DE3416609A1 (de) | 1984-05-05 | 1984-05-05 | 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten |
Publications (1)
Publication Number | Publication Date |
---|---|
MC1651A1 true MC1651A1 (fr) | 1986-04-07 |
Family
ID=6235001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC851765A MC1651A1 (fr) | 1984-05-05 | 1985-05-03 | Gluconate de l'amino-2 ethoxycarbonylamino-3(fluoro-4 benzylamino)-6 pyridine et compositions pharmaceutiques renfermant ce compose |
Country Status (25)
Country | Link |
---|---|
US (1) | US4673666A (xx) |
EP (1) | EP0160865B1 (xx) |
JP (1) | JPS60239469A (xx) |
KR (1) | KR850008678A (xx) |
AT (1) | ATE33638T1 (xx) |
AU (1) | AU4194385A (xx) |
BG (1) | BG44537A3 (xx) |
CA (1) | CA1263398A (xx) |
CS (1) | CS248743B2 (xx) |
DD (1) | DD236927A5 (xx) |
DE (2) | DE3416609A1 (xx) |
DK (1) | DK157016C (xx) |
ES (1) | ES8603423A1 (xx) |
FI (1) | FI80443C (xx) |
GR (1) | GR851065B (xx) |
HU (1) | HU193753B (xx) |
IE (1) | IE57766B1 (xx) |
IL (1) | IL75086A (xx) |
MC (1) | MC1651A1 (xx) |
NO (1) | NO851772L (xx) |
PL (1) | PL253202A1 (xx) |
PT (1) | PT80386B (xx) |
SU (1) | SU1398772A3 (xx) |
YU (1) | YU71785A (xx) |
ZA (1) | ZA853351B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117432A (en) * | 1995-04-20 | 2000-09-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
US6689370B1 (en) | 1995-04-20 | 2004-02-10 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
FR2733151B1 (fr) * | 1995-04-20 | 1997-05-23 | Seppic Sa | Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines |
US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
DE10327674A1 (de) * | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
EP2350009B1 (en) * | 2008-06-09 | 2016-03-16 | TEVA GmbH | Sulfonate salts of flupirtine |
US8183267B2 (en) | 2008-06-09 | 2012-05-22 | Awd. Pharma Gmbh & Co. Kg | Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine |
DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
WO2012004391A1 (en) | 2010-07-09 | 2012-01-12 | K.H.S. Pharma Holding Gmbh | Process for the preparation of flupirtine maleate |
CN102850265B (zh) * | 2011-06-29 | 2015-11-25 | 陈小花 | 一种氟吡汀偶联物及其制备方法和用途 |
CN102351786A (zh) * | 2011-11-01 | 2012-02-15 | 东南大学 | 一种氟吡汀丙二酸盐及其制备方法 |
CN103910674B (zh) * | 2013-12-19 | 2015-12-02 | 天津红日药业股份有限公司 | 用于马来酸氟吡汀分析中的参比化合物 |
CN104974087A (zh) * | 2015-01-30 | 2015-10-14 | 吉林修正药业新药开发有限公司 | 一种氟吡汀二聚体的合成方法 |
DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3133519A1 (de) * | 1980-09-13 | 1982-06-09 | Degussa Ag, 6000 Frankfurt | "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat" |
US4481205A (en) * | 1980-09-13 | 1984-11-06 | Degussa Aktiengesellschaft | 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate |
-
1984
- 1984-05-05 DE DE19843416609 patent/DE3416609A1/de not_active Withdrawn
-
1985
- 1985-04-19 AT AT85104746T patent/ATE33638T1/de not_active IP Right Cessation
- 1985-04-19 EP EP85104746A patent/EP0160865B1/de not_active Expired
- 1985-04-19 DE DE8585104746T patent/DE3562242D1/de not_active Expired
- 1985-04-26 SU SU853884101A patent/SU1398772A3/ru active
- 1985-04-29 YU YU00717/85A patent/YU71785A/xx unknown
- 1985-04-30 CS CS853157A patent/CS248743B2/cs unknown
- 1985-05-01 US US06/729,413 patent/US4673666A/en not_active Expired - Lifetime
- 1985-05-02 GR GR851065A patent/GR851065B/el unknown
- 1985-05-02 DD DD85275890A patent/DD236927A5/de unknown
- 1985-05-02 DK DK198785A patent/DK157016C/da not_active IP Right Cessation
- 1985-05-03 AU AU41943/85A patent/AU4194385A/en not_active Abandoned
- 1985-05-03 HU HU851691A patent/HU193753B/hu unknown
- 1985-05-03 CA CA000480723A patent/CA1263398A/en not_active Expired
- 1985-05-03 NO NO851772A patent/NO851772L/no unknown
- 1985-05-03 BG BG070073A patent/BG44537A3/xx unknown
- 1985-05-03 ZA ZA853351A patent/ZA853351B/xx unknown
- 1985-05-03 PL PL25320285A patent/PL253202A1/xx unknown
- 1985-05-03 PT PT80386A patent/PT80386B/pt unknown
- 1985-05-03 IL IL75086A patent/IL75086A/xx unknown
- 1985-05-03 ES ES542817A patent/ES8603423A1/es not_active Expired
- 1985-05-03 IE IE1117/85A patent/IE57766B1/en not_active IP Right Cessation
- 1985-05-03 MC MC851765A patent/MC1651A1/xx unknown
- 1985-05-03 FI FI851752A patent/FI80443C/fi not_active IP Right Cessation
- 1985-05-04 KR KR1019850003047A patent/KR850008678A/ko not_active Application Discontinuation
- 1985-05-07 JP JP60095714A patent/JPS60239469A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MC1651A1 (fr) | Gluconate de l'amino-2 ethoxycarbonylamino-3(fluoro-4 benzylamino)-6 pyridine et compositions pharmaceutiques renfermant ce compose | |
OA08487A (fr) | Process for preparation of aloe products, products produced thereby and compositions thereof. | |
BE893010A (fr) | Compose stable de sulfate de glucosamine, son procede de preparation et compositions pharmaceutiques les contenant | |
NL991002I1 (nl) | Gesubstitueerde pyridinesulfonamideverbindingen, herbicide preparaten die deze bevatten en werkwijzeter bereiding van deze verbindingen. | |
PT80921A (fr) | Procede de preparation de derives d'acylaminomethyl-3-imidazo<1,2-a>pyridines et de compositions pharmaceutiques les contenant | |
BE893943A (fr) | 26,26,26,27,27,27-hexafluoro-1alpha,25-dihydroxycholecalciferol et derives de ce compose | |
DE3576328D1 (de) | Behandlung feuerfester gegenstaende. | |
MA20316A1 (fr) | Compose antibiotique,procede pour le preparer et compositions les contenant | |
FR2567519B1 (fr) | Nouvelles isoindolinyl-alcoyl-piperazines, compositions pharmaceutiques les contenant, et leur procede de preparation | |
BR8201194A (pt) | Preparacao de 2,3-dicloro-5-triclorometilpiridina | |
FR2599039B1 (fr) | Nouvelle substance immuno-suppressive, sa preparation par culture de streptomyces sp. (cbs 162.86) et les compositions pharmaceutiques qui la contiennent | |
OA06776A (fr) | Procédé de préparations pharmaceutiques. | |
SE7407296L (xx) | ||
SE9004169D0 (sv) | Anvaendning av farmaceutiska och kosmetiska kompositioner, innehaallande 1,8-dihydroxi-10-fenyl-9-antron som verksam bestaandsdel | |
PT70107A (fr) | Procede de preparation de nouveaux derives de 1,3-benzoxazine-2,4-dione et des compositions pharmaceutiques les contenant | |
DE3768321D1 (de) | Balsamduftstoffkomposition und ihr herstellungsverfahren. | |
OA08088A (fr) | Nouveau procédé de préparation des dérivés de la furo-(3,4-C)-pyridine substitués en position 6. | |
PT78428A (fr) | Procede de preparation de diphenylazomethines et de compositi- ons pharmaceutiques les contenant | |
IT8522067A0 (it) | Derivati di 6-aminometil-furo-(3,4-c)-piridina, loro preparazione e composizioni farmaceutiche contenenti glistessi. | |
FR2609030B1 (fr) | Nouvelles aminoalcanoyldibenzo (d, q) (1,3,6) dioxazocines, leur procede de preparation et compositions pharmaceutiques les contenant | |
PH16951A (en) | Thioalkylamide of 1-oxide nicotinic acid,its salts process for the preparation thereof and pharmaceutical compositions | |
BE893057A (fr) | Derives de beta-lactame, les compositions pharmaceutiques les contenant et leur procede de preparation | |
OA08271A (fr) | Naphtyridinones-1,8 substituées, procédé pour leur obtention et compositions pharmaceutiques les contenant. | |
PT88578A (pt) | Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them | |
DE2961633D1 (en) | Beta-lactam antibacterial agents, their pharmaceutical compositions and process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
YP | Annual fee paid |